Trustmark National Bank Trust Department Acquires 911 Shares of The Allstate Co. (NYSE:ALL)

Trustmark National Bank Trust Department boosted its stake in The Allstate Co. (NYSE:ALL) by 10.7% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,417 shares of the insurance provider’s stock after purchasing an additional 911 shares during the quarter. Trustmark National Bank Trust Department’s holdings in Allstate were worth $1,786,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also bought and sold shares of the company. Acadian Asset Management LLC lifted its stake in Allstate by 154.2% during the first quarter. Acadian Asset Management LLC now owns 10,564 shares of the insurance provider’s stock worth $1,825,000 after purchasing an additional 6,409 shares during the last quarter. Edgestream Partners L.P. purchased a new position in shares of Allstate during the first quarter worth approximately $498,000. CreativeOne Wealth LLC lifted its holdings in shares of Allstate by 12.5% in the 1st quarter. CreativeOne Wealth LLC now owns 6,113 shares of the insurance provider’s stock worth $1,057,000 after acquiring an additional 677 shares during the last quarter. Canada Pension Plan Investment Board boosted its stake in shares of Allstate by 97.5% in the 1st quarter. Canada Pension Plan Investment Board now owns 271,464 shares of the insurance provider’s stock valued at $46,966,000 after purchasing an additional 134,028 shares in the last quarter. Finally, Quadrature Capital Ltd grew its holdings in shares of Allstate by 5.6% during the 1st quarter. Quadrature Capital Ltd now owns 49,129 shares of the insurance provider’s stock valued at $8,500,000 after purchasing an additional 2,612 shares during the last quarter. 76.47% of the stock is currently owned by institutional investors.

Allstate Stock Performance

Shares of ALL opened at $197.29 on Thursday. The Allstate Co. has a 52 week low of $134.17 and a 52 week high of $201.00. The company has a quick ratio of 0.40, a current ratio of 0.40 and a debt-to-equity ratio of 0.43. The stock has a market cap of $52.24 billion, a P/E ratio of 12.78, a P/E/G ratio of 1.76 and a beta of 0.48. The business’s 50 day moving average price is $190.76 and its 200-day moving average price is $177.36.

Allstate (NYSE:ALL) last released its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, topping analysts’ consensus estimates of $2.20 by $1.71. The firm had revenue of $16.63 billion for the quarter, compared to analysts’ expectations of $14.57 billion. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The company’s quarterly revenue was up 14.7% on a year-over-year basis. During the same period in the prior year, the firm posted $0.81 earnings per share. Equities research analysts anticipate that The Allstate Co. will post 16.01 earnings per share for the current fiscal year.

Allstate Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, January 2nd. Stockholders of record on Friday, November 29th will be issued a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a dividend yield of 1.87%. The ex-dividend date is Friday, November 29th. Allstate’s payout ratio is 23.83%.

Analysts Set New Price Targets

ALL has been the subject of several analyst reports. Jefferies Financial Group upped their price target on shares of Allstate from $231.00 to $267.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Bank of America raised their price target on Allstate from $216.00 to $233.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. BMO Capital Markets boosted their price objective on Allstate from $205.00 to $214.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. Barclays raised their target price on shares of Allstate from $175.00 to $187.00 and gave the stock an “underweight” rating in a report on Thursday, October 31st. Finally, Morgan Stanley upped their price target on shares of Allstate from $220.00 to $228.00 and gave the company an “overweight” rating in a report on Thursday, November 7th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $214.19.

Insider Activity at Allstate

In other news, insider John E. Dugenske sold 36,367 shares of the company’s stock in a transaction on Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the transaction, the insider now directly owns 27,364 shares of the company’s stock, valued at $5,236,922.32. This represents a 57.06 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 1.80% of the stock is owned by insiders.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.